News
Orexo Enters Into Collaboration With Abera To Develop Nasal Powder Vaccines Based On The Amorphox Technology
(MENAFN - PR Newswire) The collaboration is in line with Orexo's strategy to broaden the use of its powder-based drug delivery technology AmorphOX–. Abera is a developer ...
By: menafn
- Dec 17 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS